Fans are cheering on DJ Khaled as he shows off his slimmed-down figure after taking weight loss medication and walking. Read ...

Scientists are taking a closer look at the pill forms of Wegovy and Ozempic. In an animal study, the ingredient SNAC, which helps semaglutide survive the stomach and enter the bloodstream, was ...

GLP-1s were first approved in 2005 for the treatment of Type 2 diabetes. Since then, more versions of the medication have hit the market, becoming more accessible to patients and used for a wider ...

Weight loss drugs are more popular than ever, even in cycling, but do the health benefits some are seeing outweigh the risks ...

Walgreens is wading into the self-pay GLP-1 space, going head-to-head with telehealth subscription offerings. | Walgreens is wading into the self-pay GLP-1 space, going head-to-head with telehealth ...

“GLP‑1s have effectively created a third pillar of pharmacy spend and most employers don't yet have a mature playbook to manage it,” Conway said, adding that over half of employers now cite GLP‑1s as ...

Can you have too much protein, do some people need more than others, and what are the best protein sources? A bariatric ...

GLP-1 cost pressure is now a talent retention issue. A new study found that 29% of employees would switch jobs for coverage.

U.S. adult obesity rates have declined for the first time in years, while South Carolina's rate remains among the nation’s highest. What to know ...

Discover the latest updates on the weight loss drug market, including Lilly's Zepbound, Hims & Hers, and NovoNordisk's price cuts.

Shares of Novo Nordisk (NVO 0.29%) sank 20% this week, according to data from S&P Global Market Intelligence. The drugmaker ...